Drug Profile
Anti-idiotype breast cancer vaccine 11D10
Alternative Names: 11D10; Anti-idiotype monoclonal antibody 11D10; Monoclonal antibody 11D10Latest Information Update: 01 May 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Cancer vaccines; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer
Most Recent Events
- 15 Apr 1999 A clinical study has been added to the adverse events section and the Cancer immunogenicity section (739418
- 08 Sep 1998 Profile reviewed
- 27 Aug 1996 Preclinical development for Breast cancer in USA (Unknown route)